Isoliquiritigenin has a good effect on anti-tumor and AIDS and inhibits angiogenic TGF-β and VEGF signaling through miR-194-5p and lncRNA NEAT1, providing a new therapeutic strategy for human glioma (146). Here, VEGFA is linked to neoplasm.